Clinical Trial Update: Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder [NA]

View source ↗

Summary

This clinical trial update reports completion of a study evaluating atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Substance Use Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Denver Health and Hospital Authority | Conditions: Attention Deficit Hyperactivity Disorder, Substance Abuse | NA | Status: COMPLETED | Results posted: 2015-07-08